Managers

Aetion pockets $36.4 mln Series B

New York City-based Aetion, a provider of real-world analytics and evidence for biopharma customers and payers, has raised $36.4 million in Series B funding. New Enterprise Associates led the round with participation from Amgen Ventures, Flare Capital Partners, Lakestar and Oxeon Ventures. In addition to the funding, Mohamad Makhzoumi of NEA will join Aetion's board of directors.

RubrYc nets $10 mln

RubrYc Therapeutics Inc, a biotherapeutics discovery business, has secured $10 million in funding. Third Point Ventures led the round with participation from Paladin Capital Group and Vital Venture Capital.

Kidney care company Somatus procures $11 mln Series B

Somatus, a kidney care company, has secured $11 million in Series B funding. Flare Capital Partners led the round with participation from other investors that included BlueCross BlueShield Venture Partners and Inova Health System.

TCV, Spark, Polaris lead mid-decade portfolio for LA pension

Conductive Ventures raises $100 mln fund for expansion stage investing

Conductive Ventures said it raised $100 million for a maiden venture capital fund aimed at expansion stage investing in hardware and enterprise software.

Silicon Valley Data Capital raises $59 mln toward venture capital fund

Silicon Valley Data Capital said it has added more capital to its venture-capital fund with a total of $59 million raised, according to a filing with the SEC.

EU launches new venture funds of funds program

The European Commission said it launched Venture EU, a program to encourage venture investing backed by about $506 million of funding.

Pappas Capital appoints Mathers as partner

Pappas Capital, which invests in the life sciences sector, has named Thomas Mathers as a partner. Previously, Mathers was CEO of CoLucid Pharmaceuticals, which is backed by Pappas Capital.

Frazier Healthcare raises $780 mln growth buyout fund

Is Zuora’s IPO another unicorn in the making?